Non-opioid Pain Treatment: Global Markets to 2024

December 2019 | 165 pages | ID: N4B889FF5E2EN
BCC Research

Abstracts

REPORT SCOPE:

This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for pain management. The geographical scope of this study is global. This study addresses acute versus chronic pain, treatments and regulatory issues facing healthcare workers. Also provided is detailed information based on product categories, use of products, forecasts and competitive analyses.

The report identifies five general product segments for Non-opioid treatment of pain %li%

• Medical cannabis treatments.
• Capsaicin-derived treatments.
• Menthol-containing treatments.
• Omega 3 fatty acid-containing treatments.
• Botulinum toxins.

Within the segment several sub-segments are discussed as they pertain to each product segment; diseases or disorders are the basis for these sub-segments, including %li%

• Arthritis.
• Cancer–brain, breast, colorectal, leukemia/lymphoma, melanoma, prostate, others.
• Dental.
• Epilepsy.
• Fibromyalgia.
• Migraine.
• Multiple sclerosis.
• Surgical.

A regional analysis of these product segments is also provided, including the specific countries listed below and including countries not listed as a “rest of the world” market.

• Argentina.
• Australia/New Zealand.
• Brazil.
• Canada.
• China.
• France.
• Germany.
• Italy.
• Japan.
• Mexico.
• Russia.
• Spain.
• United Kingdom.
• United States.

Each market segment provides detailed information based on product categories, product use, current market value and forecasts.

Not covered in the report are drugs or devices that are considered “conventional” in professional treatment guidelines that are due to either controversial issues such as those with medical cannabis or those that are not commonly prescribed or recommended due to a lack of clinical data, education or other factors.

REPORT INCLUDES:

• 44 data tables and 19 additional tables
• An overview of the global market for Non-opioid pain treatments
• Analyses of global market trends, with data from 2018 and 2019, and projections of compound annual growth rates (CAGRs) through 2024
• Description of products included in this market, and a detailed analysis of the markets and market opportunities
• Information on significant products categories, issues and trends, market influences, regulatory issues and other information affecting the pain management industry
• Briefing about major drivers and regional dynamics of the market and current trends within the industry
• Comprehensive profiles of major vendors in the market, including Allergan PLC, Canopy Growth Corp., Medical Marijuana Inc., Panag Pharma Inc., and Tilray

Contents

CHAPTER 1 INTRODUCTION

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst’s Credentials
BCC Custom Research
Related BCC Research Reports

CHAPTER 2 SUMMARY AND HIGHLIGHTS

Market Overview
Drivers and Restraints

CHAPTER 3 MARKET OVERVIEW AND BACKGROUND

Definition of Pain and Nociception
Pain
Nociception
History of Pain and Pain Treatment
Types of Pain
Acute Pain
Chronic Pain
Physiological Pain Classifications
How Pain is Diagnosed
How Pain is Treated
Opioid vs. Non-opioid Pain Control
Opioids, also Known as Narcotic Analgesics
Full and Partial Agonists
Agonist-Antagonists
Risk and Complications in Opioid Pain Treatment
Addiction and Abuse
Challenges of Breakthrough Pain Control
Alternative Methods of Pain Management
Alternative Non-opioid Therapies for Treating Pain
Medical Cannabis
Capsaicin-derived Compound
Menthol-containing Compound
Omega 3 Fatty Acid-containing Supplements
Botulinum Toxins (OnabotulinumtoxinA/RimabotulinumtoxinB)
Others
Growing Trend in Cannabis Treatment for Pain
Adoption of Medical Cannabis: A Global Analysis
Laws and Legalization Trends
Claims in Effectiveness
Potency and Validation Testing Trends
Hospice Care
Access to Palliative Care Around the World
Assessing the Need for Palliative Care
Market Influences and Indicators of Growth
Demographic Overview
Incidence and Prevalence of Conditions with Pain Symptoms

CHAPTER 4 MARKET BREAKDOWN BY PRODUCT SEGMENT

Overview
Medical Cannabis
Capsaicin-derived Therapies
Menthol-containing Therapies
Omega-3 Fatty Acid-containing Therapies
Botulinum Toxin Treatments

CHAPTER 5 MARKET BREAKDOWN BY THERAPEUTIC APPLICATION

Overview
Alternative Non-opioid Cancer Pain Treatment
Alternative Non-opioid Neuropathic Pain Treatment
Alternative Non-opioid Orthopedic/Musculoskeletal Pain Treatments
Other Alternative Non-Opioid Pain Treatments

CHAPTER 6 MARKET BREAKDOWN BY REGION

Overview
Regional Groupings
North America
North America: Pioneer in the Medicinal Cannabis Industry
Canada
United States
EMEA
France
Germany
Italy
Russia
Spain
United Kingdom
Asia-Pacific
Australia/New Zealand
China
Japan
Latin America
Argentina
Brazil
Mexico

CHAPTER 7 PATENT ANALYSIS

Patent Analysis Overview
Non-opioid Pain Relief Categories
Medical Cannabis
Technologies
Cannabis Patent Review by Year
Patent Review by Company
Patent Review by Assignee

CHAPTER 8 COMPANY PROFILES

ALLERGAN PLC
APHRIA INC.
AURORA
BEDROCAN
CANOPY GROWTH CORP.
CARA THERAPEUTICS
CENTREXION THERAPEUTICS
CHT MEDICAL
CRONOS GROUP
GW PHARMACEUTICALS
MEDICAL MARIJUANA INC.
MEDROPHARM GMBH
PANAG PHARMA INC.
TILRAY
US WORLDMEDS LLC
VANWAY

CHAPTER 9 APPENDIX: TERMINOLOGY AND SOURCES OF INFORMATION

List Of Tables

LIST OF TABLES

Table A: Major Countries, by Region
Summary Table: Global Market for Non-opioid Pain Treatments, by Product Segment, Through 2024
Table 1: Physiological Effects of Pain
Table 2: United States Opioid Addiction and Abuse Statistics
Table 3: Global Opioid Addiction and Abuse Statistics
Table 4: List of Brand Name Extended-release and Long-acting Opioid Products Required to be Included in Opioid REMS, May 2017
Table 5: List of Generic Extended-release and Long-acting Opioid Products Required to be Included in Opioid REMS, May 2017
Table 6: List of Transmucosal Immediate-release Fentanyl Products Required to be Included in the TIRF REMS Access Program
Table 7: Adoption of Medical Cannabis, by Country (Age 15 and Over), 2017
Table 8: Medical Cannabis Programs, by U.S. State, 1998-2017
Table 9: Top Five U.S. States with Medical Cannabis Applications/Registrations
Table 10: Effectiveness of Fibromyalgia Treatments: Cannabis vs. Pharmaceutical Therapies
Table 11: Hospice Statistics, Patient Characteristics, 2009-2014
Table 12: Hospice Statistics, Patients, by Primary Diagnosis, 2009-2014
Table 13: Global Population, by Country/Region, Through 2024
Table 14: Global Population, Age 65+, by Country/Region, Through 2024
Table 15: Global Life Expectancy at Birth, by Country/Region, 1980, 2010 and 2020 Projections (Both Genders Combined)
Table 16: Global Non-opioid Pain Treatment Market, by Product Segment, Through 2024
Table 17: Global Market Shares of Non-opioid Pain Treatments, by Product Segment, 2018
Table 18: Selected Cannabis Clinical Trials for Pain Treatment, Through Nov. 30, 2018
Table 19: Global Medical Cannabis Pain Treatment Market, by Indication, Through 2024
Table 20: Global Market Shares of Medical Cannabis Pain Treatments, by Indication, 2018
Table 21: Selected Capsaicin-derived Clinical Trials for Pain Treatment, Through Nov. 30, 2019
Table 22: Global Capsaicin-derived Pain Treatment Market, by Indication, Through 2024
Table 23: Global Market Shares of Capsaicin-derived Pain Treatments, by Indication, 2018
Table 24: Clinical Trials on Menthol Containing Non-Opioid Pain Therapeutics for Diabetic Neuropathic Pain, Through Nov. 30, 2017
Table 25: Global Menthol-containing Pain Treatment Market, by Indication, Through 2024
Table 26: Selected Omega-3 Fatty Acid-containing Clinical Trials for Pain Treatment, Through Nov. 30, 2019
Table 27: Selected Omega-3 Fatty Acid-containing Clinical Trials for Pain Treatment, Through Nov. 30, 2019
Table 28: Global Omega-3 Fatty Acid-containing Pain Treatment Market, by Indication, Through 2024
Table 29: Global Market Shares of Omega-3 Fatty Acid-containing Pain Treatments, by Indication, 2018
Table 30: U.S. Market for Allergan’s Botox, by Treatment Area, 2018
Table 31: Selected Botulinum Toxin Clinical Trials for Pain Treatment, Through Nov. 30, 2017
Table 32: Global Botulinum Toxin Pain Treatment Market, by Indication, Through 2024
Table 33: Global Market for Botulinum Toxin Pain Treatments, by Indication, 2018
Table 34: Global Non-opioid Pain Treatment Market, by Therapeutic Application, Through 2024
Table 35: Global Market Shares of Non-opioid Pain Treatments, by Therapeutic Application, 2018
Table 36: Global Non-opioid Cancer Pain Treatment Market, by Product Segment, Through 2024
Table 37: Global Market Shares of Non-opioid Cancer Pain Treatments, by Product Segment, 2018
Table 38: Global Market Shares of Non-opioid Cancer Pain Treatments, by Cancer Type, 2018
Table 39: Global Non-opioid Neuropathic Pain Treatment Market, by Product Segment, Through 2024
Table 40: Global Market Shares of Non-opioid Neuropathic Pain Treatments, by Product Segment, 2018
Table 41: Global Market Shares of Non-opioid Neuropathic Pain Treatments, by Disease/Disorder Type, 2018
Table 42: Global Non-opioid Orthopedic/Musculoskeletal Pain Treatment Market, by Product Segment, Through 2024
Table 43: Global Market Shares of Non-opioid Orthopedic/Musculoskeletal Pain Treatments, by Product Segment, 2018
Table 44: Global Market Shares of Non-opioid Orthopedic/Musculoskeletal Pain Treatments, by Disease/Disorder Type, 2018
Table 45: Global Market for Other Non-opioid Pain Treatments, by Product Segment, Through 2024
Table 46: Global Market Shares of Other Non-opioid Pain Treatments, by Product Segment, 2018
Table 47: Global Market Shares of Other Non-opioid Pain Treatments, by Disease/Disorder Type, 2018
Table 48: Global Non-opioid Pain Treatment Market, by Region, Through 2024
Table 49: Global Market Shares of Non-opioid Pain Treatments, by Region, 2018
Table 50: Regional Grouping: Countries, by Region
Table 51: North American Non-opioid Pain Treatment Market, by Country, Through 2024
Table 52: EMEA Non-opioid Pain Treatment Market, by Country, Through 2024
Table 53: Asia-Pacific Non-opioid Pain Treatment Market, by Country, Through 2024
Table 54: Latin American Non-opioid Pain Treatment Market, by Country, Through 2024
Table 55: U.S. Patents Related to Medical Cannabis, by Type, Through 2018
Table 56: U.S. Patents on Medical Cannabis Technologies, by Type, Through 2018
Table 57: Notable U.S. Patents Related to Medical Cannabis, by Company, Through 2018
Table 58: List of U.S. Patents Related to Medical Cannabis, July 2017-Nov. 2017
Table 59: Notable Developments in Non-opioid Pain Relief, 2000-2017
Table 60: Glossary of Terms Used in Non-opioid Pain Treatment
Table 61: Global Pain Societies and Organizations
Table 62: Report Sources

List Of Figures

LIST OF FIGURES

Summary Figure: Global Market for Non-opioid Pain Treatments, by Product Segment, 2018-2024
Figure 1: Non-opioid Pain Management Market Drivers and Restraints
Figure 2: Pain Management Techniques
Figure 3: Total Hospice Patients Served, by Year, 2009-2014
Figure 4: Distribution of Causes of Mortality and Potential Need for Palliative Care, 2018
Figure 5: Global Population, by Country/Region, 2019 and 2024
Figure 6: Global Population Age 65+, by Country/Region, 2019 and 2024
Figure 7: Global Life Expectancy at Birth, by Country/Region, 1980, 2010 and 2020 Projections (Both Genders Combined)
Figure 8: Global Non-opioid Pain Treatment Market, by Product Segment, 2018-2024
Figure 9: Global Market Shares of Non-opioid Pain Treatments, by Product Segment, 2018
Figure 10: Global Market Shares of Medical Cannabis: Pain vs. All Other Uses, 2018
Figure 11: Global Medical Cannabis Pain Treatment Market, by Indication, 2018-2024
Figure 12: Global Market Shares of Medical Cannabis Pain Treatments, by Indication, 2018
Figure 13: Global Capsaicin-derived Pain Treatment Market, by Indication, 2018-2024
Figure 14: Global Market Shares of Capsaicin-derived Pain Treatments, by Indication, 2018
Figure 15: Global Menthol-containing Pain Treatment Market, by Indication, 2018-2024
Figure 16: Global Market Shares of Menthol-containing Pain Treatments, by Indication, 2018
Figure 17: Global Omega-3 Fatty Acid-containing Pain Treatment Market, by Indication, 2018-2024
Figure 18: Global Market Shares of Omega-3 Fatty Acid-containing Pain Treatments, by Indication, 2018
Figure 19: Global Botulinum Toxin Pain Treatment Market, by Indication, 2018-2024
Figure 20: Global Market Shares of Botulinum Toxin Pain Treatments, by Indication, 2018
Figure 21: Global Non-opioid Pain Treatment Market, by Therapeutic Application, 2019-2024
Figure 22: Global Market Shares of Non-opioid Pain Treatments, by Therapeutic Application, 2018
Figure 23: Global Non-opioid Cancer Pain Treatment Market, by Product Segment, 2018-2024
Figure 24: Global Market Shares of Non-opioid Cancer Pain Treatments, by Product Segment, 2018
Figure 25: Global Market Shares of Non-opioid Cancer Pain Treatments, by Cancer Type, 2018
Figure 26: Global Non-opioid Neuropathic Pain Treatment Market, by Product Segment, 2018-2024
Figure 27: Global Market Shares of Non-opioid Neuropathic Pain Treatments, by Product Segment, 2018
Figure 28: Global Market Shares of Non-opioid Neuropathic Pain Treatments, by Disease/Disorder Type, 2018
Figure 29: Global Non-opioid Orthopedic/Musculoskeletal Pain Treatment Market, by Product Segment, 2018-2024
Figure 30: Global Market Shares of Non-opioid Orthopedic/Musculoskeletal Pain Treatments, by Product Segment, 2018
Figure 31: Global Market Shares of Non-opioid Orthopedic/Musculoskeletal Pain Treatments, by Disease/Disorder Type, 2018
Figure 32: Global Market for Other Non-opioid Pain Treatments, by Product Segment, 2018-2024
Figure 33: Global Market Shares of Other Non-opioid Pain Treatments, by Product Segment, 2018
Figure 34: Global Market Shares of Other Non-opioid Pain Treatments, by Disease/Disorder Type, 2018
Figure 35: Global Non-opioid Pain Treatment Market, by Region, 2018-2024
Figure 36: Global Market Shares of Non-opioid Pain Treatments, by Region, 2018
Figure 37: North American Non-opioid Pain Treatment Market, by Country, 2018-2024
Figure 38: North American Market Shares of Alternative Non-opioid Pain Treatments, by Country, 2018
Figure 39: Canadian Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
Figure 40: Canadian Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
Figure 41: U.S. Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
Figure 42: U.S. Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
Figure 43: EMEA Non-opioid Pain Treatment Market, by Country, 2018-2024
Figure 44: EMEA Market Shares of Alternative Non-opioid Pain Treatments, by Country, 2018
Figure 45: French Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
Figure 46: French Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
Figure 47: German Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
Figure 48: German Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
Figure 49: Italian Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
Figure 50: Italian Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
Figure 51: Russian Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
Figure 52: Russian Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
Figure 53: Spanish Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
Figure 54: Spanish Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
Figure 55: U.K. Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
Figure 56: U.K. Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
Figure 57: Asia-Pacific Non-opioid Pain Treatment Market, by Country, 2018-2024
Figure 58: Asia-Pacific Market Shares of Alternative Non-opioid Pain Treatments, by Country, 2018
Figure 59: Australia/New Zealand’s Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
Figure 60: Australia/New Zealand’s Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
Figure 61: Chinese Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
Figure 62: Chinese Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
Figure 63: Japanese Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
Figure 64: Japanese Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
Figure 65: Latin American Non-opioid Pain Treatment Market, by Country, 2018-2024
Figure 66: Latin American Market Shares of Alternative Non-opioid Pain Treatments, by Country, 2018
Figure 67: Argentinean Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
Figure 68: Argentinean Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
Figure 69: Brazilian Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
Figure 70: Brazilian Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
Figure 71: Mexican Market Shares of Alternative Non-opioid Pain Treatments, by Product Segment, 2018
Figure 72: Mexican Market Shares of Alternative Non-opioid Pain Treatments, by Application, 2018
Figure 73: Total U.S. Patents on Non-opioid Pain Treatments, by Type, Through 2018
Figure 74: Shares of U.S. Patents Related to Medical Cannabis, by Type, Through 2018
Figure 75: Shares of U.S. Patents on Medical Cannabis Technologies, by Type, Through 2018